Novel presenilin 1 variant (P117A) causing Alzheimer's disease in the fourth decade of life

Neurosci Lett. 2008 Jun 20;438(2):257-9. doi: 10.1016/j.neulet.2008.04.029. Epub 2008 Apr 15.

Abstract

Over 160 rare genetic variants in presenilin 1 (PSEN1) are known to cause Alzheimer's disease (AD). In this study we screened a family with early-onset AD for mutations in PSEN1 using direct DNA sequencing. We identified a novel PSEN1 genetic variant which results in the substitution of a Proline with an Alanine at codon 117 (P117A). The P117A variant was present in all demented individuals and fifty percent of at risk individuals. This variant occurs at a site where three other disease-causing variants have been previously observed. In vitro functional studies demonstrate that the P117A variant results in an altered Abeta42/total Abeta ratio consistent with an AD causing mutation. The P117A variant is a novel mutation in PSEN1, which causes early-onset AD in an autosomal dominant manner.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alzheimer Disease / genetics*
  • Alzheimer Disease / physiopathology
  • Amino Acid Substitution / genetics
  • Amyloid beta-Peptides / genetics
  • Brain / metabolism*
  • Brain / physiopathology
  • Cell Line
  • Chromosome Disorders / genetics
  • DNA Mutational Analysis
  • Disease Progression
  • Female
  • Gene Frequency
  • Genes, Dominant / genetics
  • Genetic Markers / genetics
  • Genetic Predisposition to Disease / genetics*
  • Genetic Testing
  • Genotype
  • Humans
  • Male
  • Pedigree
  • Peptide Fragments / genetics
  • Point Mutation / genetics
  • Polymorphism, Genetic / genetics*
  • Presenilin-1 / biosynthesis
  • Presenilin-1 / genetics*

Substances

  • Amyloid beta-Peptides
  • Genetic Markers
  • Peptide Fragments
  • Presenilin-1
  • amyloid beta-protein (1-42)